Interferon for genital warts (human papillomavirus) - [Medication] - Quest Diagnostics Patient Health Library Interferon for genital warts (human papillomavirus) Examples Brand Name Chemical Name Roferon-A interferon alfa-2a Intron A interferon alfa-2b Alferon N interferon alfa-n3 Betaseron interferon beta-1b Actimmune interferon gamma -1b How It Works Interferon can kill viruses and prevent them from reproducing; it also...
Biotech Tracker: InterMune’s INSPIRE Trial Underway - - - - BioNews BioWeb Companies Products BioReports - - - - - Channels Select Channel -------> Channels Home Page BioWeb Search BioNews Search BioNews Topics BioWatch Tracking BioJob Career Bio/Pharma Events BioNewsCast BioCorporate BioReports Indication/Disease BioZak CD-rom BioTechnologies BioExecutive BioEquities/Stocks BioDrug Discovery BioJournal BioAnalysis BioSuppliers...
Biotech Tracker: Actimmune Fails in HCV Trial InterMune’s (NASDAQ: ITMN) Actimmune (interferon gamma -1b) failed to meet its primary endpoint in an exploratory phase II clinical trial assessing its use for advanced liver cirrhosis caused by antiviral-refractory hepatitis C virus (HCV) infection.
BiotechTracker - Actimmune Data at the American Thoracic Society Meeting Clinical data include: Raghu et al published Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of Interferon Gamma -1b (IFN- 1b) in Patients with Idiopathic Pulmonary Fibrosis (IPF) 330 study subjects randomized to Actimmune or placebo SQ thrice weekly for up to 3 years prespecified data cutoff for primary analysis = 48 wk after randomization of...
BioPortfolio Limited Cancer Overview - Numerous Diverse Drugs Approaching Fruition TABLE OF CONTENTS About the Oncology pharmaceutical analysis team 2 Richard Faint – Director of Oncology 2 CHAPTER 1 KEY FINDINGS 3 Datamonitor insight into the oncology market 3 Key metrics 9 Datamonitor pipeline assessment summary 17 CHAPTER 2 CANCER PATIENT POTENTIAL 38 Introduction 38 Definition of cancer 38...
Approved Products_2004.xls Number A pproval Date Trade Name Generic/ Chemical name Indication Company 1 Oct- 82 Humulin Human Insulin Type I Diabetes Lilly / Genentech 2 Oct- 85 Protro pin Human Growth Hormone Hypoptuitary dwarfism Genentech 3 Jun- 86 Intron A Interferon Al pha 2B Hairy Cell Leukemia Schering Plough / Biogen 4 Jun- 86 OKT- 3 Anti CD3 Mab Acute Trans plant Rejection JNJ / OrthoBiotech 5...
author: Reijer
Approved Products_2004.xls page 1
author: Reijer
http://www.amarbio.com/AJVR.pdf page 10
Database A A - investigational drugs, therapies and vaccines # - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z From this page you may order documents with information covering investigational products.Actimmune ®* (Imukin®, ...
Database I See hFAT (3321) IGN101 Vaccine (3250) IGN201 Vaccine (3252) IGN301 Vaccine (3249) IGN311 Antibody (HuABL346, Anti-Lewis Y Antibody) (2963) IGN402 Vaccine (3253) IL-1 (Interleukin-1) Receptor Type II (1943) IL-1 Trap (Interleukin-1 Trap) (2254) IL-12 Cytokine Combination (1594) IL-12 (Interleukin-12) Interferon -alfa Combination Gene Medicine (1593) IL-13R alpha2 (Interleukin-13...
http://www.gene.com/gene/ir/financials/annual-reports/2003/financials/form10k.pdf UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DInterferon gamma - 1b ...Actimmune Connetics Corporation (which transferred rights to InterMune Pharmaceuticals, Inc.)...
http://www.gene.com/gene/ir/financials/annual-reports/2003/financials/form10k.pdf page 5
Therapeutic Biological Approvals Approval Date Abbokinase Urokinase For adults for the lysis of acute massive pulmonary emboli, defined as obstruction of blood flow to a lobe or multiple segments, and for the lysis of pulmonary emboli accompanied by unstable hemodynamics, i.e., failure to maintain blood pressure without supportive measures 76-1021 / 076 Abbott Laboratories 200 Abbott Park Road Dept 037N, j45-2...
New Topics Diagnostic Imaging Computer-Aided Detection in Screening Mammography (October 2002) Doppler Flow Testing of Vascular Access Grafts (October 1998) FDG SPECT for Diagnosing Ischemic Heart Disease (January 1998) Helical CT for Detection of Lung Cancer (April 2002) Magnetic Resonance Imaging for Diagnosis of Breast Cancer (May 2001) PET for Diagnosis of Alzheimer's Disease (November 2002...
CBER Approval Letter, Interferon gamma-1b to include a new indication for delaying time to disease progression in patients with Ellis: Your request to supplement your biologics license application for Interferon gamma -lb to include a new indication for delaying time to disease progression in patients with severe, malignant osteopetrosis has been approvedInterferon gamma -lb
Interferon gamma-1b - Product Approval Information - Licensing Action FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER - Search - -Interferon gamma -1b Product Approval Information - Licensing Action Proper name: Interferon gamma -1b Tradename: Actimmune Manufacturer: InterMune Pharmaceuticals, Inc, Palo Alto, CA, License #1267 New Indication for Use:Delaying time to disease...
http://www.easy.no/affitech/pdf/das1.pdf page 1
duplicates:http://www.iscpubs.com/articles/abl/b0002das.pdf
Prescription Drug User Fee Act - User Fee Billable Therapeutic Products: Approved Under Section 351 of the PHS Act License 1178 ReoPro Abciximab 103575/0 12/22/1994 2 mg/mL Centocor, Inc License 1242 Remicade Infliximab 103772/0 8/24/1998 100 mg/vial Retavase Reteplase 103786/0 5/6/1998 18.8 mg/vial Chiron Corp License 1106 Proleukin Aldesleukin 103293/0 5/5/1992 22 mg/vial Betaseron Interferon beta-1b 103471/0 7/23/1993 9.6 Mil
Interferon gamma-1b, Actimmune, InterMune Pharmaceuticals, Inc. - Approval letter page 2
author: CBER
Interferon gamma-1b, Actimmune, InterMune Pharmaceuticals, Inc. - Approval letter page 1
author: CBER
http://www.phrma.org/newmedicines/resources/2003-09-02.117.pdf Triangle Park, NC ABT 773 Abbott Laboratories influenza in clinical trials Abbott Park, IL (847) 935- 8865 Actimmune ® InterMune idiopathic pulmonary fibrosis Phase III interferon Brisbane, CA (see also other) (888) 782- 3256 gamma - 1b (Orphan Drug) Advair GlaxoSmithKline COPD application submitted beta2 agonist Philadelphia, PA (888) 825- 5249 (dry...
http://www.phrma.org/newmedicines/resources/2003-09-02.117.pdf page 23
http://www.phrma.org/newmedicines/resources/2003-09-02.117.pdf page 16
01-331 PhRMA NewMed InfDis3/8 2002 Infectious Diseases N E W M E D I C I N E S I N D E V E L O P M E N T F O R Survey P R E S E N T E D B Y A M E R I C A' S P H A R M A C E U T I C A L C O M P A N I E S A s the age- old war against infectious diseases enters a newN and frighteningN phase, pharmaceutical and biotechnology companies are rising to the heightened challenges
author: RL
duplicates:http://www.phrma.org/newmedicines/resources/2003-06-17.111.pdf http://www.phrma.org/newmedicines/resources/2003-05-12.108.pdf
01-331 PhRMA NewMed InfDis3/8 page 11
author: RL
duplicates:http://www.phrma.org/newmedicines/resources/2003-06-17.111.pdf http://www.phrma.org/newmedicines/resources/2003-05-12.108.pdf
